Fluoxetine vs Pembrolizumab

Fluoxetine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Fluoxetine and Pembrolizumab.

Mechanism of Action

Fluoxetine: Selective serotonin reuptake inhibitor (SSRI).

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Fluoxetine — 1-3 days; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Fluoxetine — C17H18F3NO.

Molecular Weight: Fluoxetine — 309.3260 g/mol.

Type: Fluoxetine — Small molecule; Pembrolizumab — Antibody.